Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing ...

The reverse stock split was approved by Kintara's stockholders at Kintara's special meeting of stockholders held on October 4, 2024, to be effected in the Board's discretion of not less than 1-for ...

SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the ...

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person ...

Gain first-hand experience of the latest experimental approaches in pharmacology and drug development, on this one-year, full-time Experimental Pharmacology and Therapeutics MSc, jointly taught by ...

Before joining Anavo, he co-founded Photys Therapeutics, serving as Chief Scientific Officer and Strategic Advisor. He previously held the roles of President and Chief Scientific Officer as a co ...

Before joining Anavo, he co-founded Photys Therapeutics, serving as Chief Scientific Officer and Strategic Advisor. He previously held the roles of President and Chief Scientific Officer as a ...